Preclinical mouse models for BRCA1-associated breast cancer

por Drost, R M, Jonkers, J
Publicado 2009

Whole-genome cancer analysis as an approach to deeper understanding of tumour biology

por Strausberg, R L, Simpson, A J G
Publicado 2010

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado 2010

How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine

por Gerlinger, M, Swanton, C
Publicado 2010

Reply: ‘Hand pattern indicates risk of prostate cancer’

por Rahman, A A, Lophatananon, A, Stewart-Brown, S, Harriss, D, Anderson, J, Parker, T, Easton, D, Kote-Jarai, Z, Pocock, R, Dearnaley, D, Guy, M, O'Brien, L, Wilkinson, R A, Hall, A L, Sawyer, E, Page, E, Liu, J-F, Eeles, R A, Muir, K-R
Publicado 2011

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours

por Rijlaarsdam, M A, van Herk, H A D M, Gillis, A J M, Stoop, H, Jenster, G, Martens, J, van Leenders, G J L H, Dinjens, W, Hoogland, A M, Timmermans, M, Looijenga, L H J
Publicado 2012

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

por Zeestraten, E C M, Maak, M, Shibayama, M, Schuster, T, Nitsche, U, Matsushima, T, Nakayama, S, Gohda, K, Friess, H, van de Velde, C J H, Ishihara, H, Rosenberg, R, Kuppen, P J K, Janssen, K-P
Publicado 2012

Breast cancer and ductal carcinoma in situ among women with prior squamous or glandular precancer in the cervix: a register-based study

por Hansen, B T, Nygård, M, Falk, R S, Hofvind, S
Publicado 2012

Endothelial cell metabolism and implications for cancer therapy

por Harjes, U, Bensaad, K, Harris, A L
Publicado 2012

Targeted anti-vascular therapies for ovarian cancer: current evidence

por Hall, M, Gourley, C, McNeish, I, Ledermann, J, Gore, M, Jayson, G, Perren, T, Rustin, G, Kaye, S
Publicado 2013

Cancer heterogeneity: implications for targeted therapeutics

por Fisher, R, Pusztai, L, Swanton, C
Publicado 2013

Exploiting inflammation for therapeutic gain in pancreatic cancer

por Steele, C W, Jamieson, N B, Evans, T R J, McKay, C J, Sansom, O J, Morton, J P, Carter, C R
Publicado 2013

Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer

por Wilson, J C, Murray, L J, Hughes, C M, Black, A, Anderson, L A
Publicado 2013

Inversion-mediated gene fusions involving NAB2-STAT6 in an unusual malignant meningioma

por Gao, F, Ling, C, Shi, L, Commins, D, Zada, G, Mack, W J, Wang, K
Publicado 2013

Exogenous hormone use, reproductive history and risk of adult myeloid leukaemia

por Poynter, J N, Fonstad, R, Blair, C K, Roesler, M, Cerhan, J R, Hirsch, B, Nguyen, P, Ross, J A
Publicado 2013

The interaction between prognostic and pharmacodynamic biomarkers

por Bouranis, L, Sperrin, M, Greystoke, A, Dive, C, Renehan, A G
Publicado 2013

Statin use is not associated with reduced risk of skin cancer: a meta-analysis

por Li, X, Wu, X B, Chen, Q
Publicado 2014

Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas

por Mäkinen, N, Heinonen, H-R, Sjöberg, J, Taipale, J, Vahteristo, P, Aaltonen, L A
Publicado 2014

Translating the molecular hallmarks of colorectal cancer to patient therapies: an interview with Owen Sansom

Publicado 2014

Morphogens, modeling and patterning the neural tube: an interview with James Briscoe

por Briscoe, James
Publicado 2015